Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 590

Results For "ED"

9539 News Found

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets
Drug Approval | September 16, 2023

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa


AstraZeneca Pharma India appoints Praveen Akkinepally as Business Unit Head - Oncology
People | September 16, 2023

AstraZeneca Pharma India appoints Praveen Akkinepally as Business Unit Head - Oncology

Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA


Strides receives tentative USFDA approval for Dolutegravir tablets
Drug Approval | September 15, 2023

Strides receives tentative USFDA approval for Dolutegravir tablets

The products will be manufactured at the company's facility in Bengaluru


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


SMi Systems secures UK patent for breakthrough single molecule imaging capabilities
Medical Device | September 15, 2023

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics


Ami Organics to supply additional API to Fermion
News | September 15, 2023

Ami Organics to supply additional API to Fermion

The product is expected to start contributing meaningfully to the revenue from FY25


Narayana Health unveils new brand identity
News | September 15, 2023

Narayana Health unveils new brand identity

The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity


Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
Policy | September 14, 2023

Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals

The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited


Bajaj Healthcare announces receipt of EIR from USFDA
Drug Approval | September 14, 2023

Bajaj Healthcare announces receipt of EIR from USFDA

The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations


Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform
News | September 14, 2023

Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform

The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades